<DOC>
	<DOC>NCT00347711</DOC>
	<brief_summary>To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.</brief_summary>
	<brief_title>Bevacizumab and Retinal Vascular Occlusions</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<criteria>Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography Previous surgery Uveitis Glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>